Properties
What is it?
International Nonproprietary Name - Saxifraga+Rubia+Cyperus+Achyranthes Description Cystone Composition Active Components: Didymocarpus pedicellata flower extract 65 mg Saxifraga ligulata stem extract 49 mg Rubia cordifolia stem extract 16 mg Cyperus scariosus rhizome extract 16 mg Achyranthes aspera seed extract 16 mg Onosma bracteatum aerial parts extract 16 mg Vernonia cinerea whole plant extract 16 mg Calcium carbonate silicate powder (Hajrul yahood bhasma) 16 mg Purified mummy powder (Shilaject Purified) 13 mg Ocimum basilicum aerial parts, Dolichos biflorus seeds, Tribulus terrestris fruit, Mimosa pudica seeds, Pavonia odorata whole plant, Equisetum arvense whole plant, Tectona grandis seeds. Excipients: Magnesium stearate, microcrystalline cellulose, sodium carboxymethylcellulose, crospovidone, aerosil. Pharmacotherapeutic Group: Urological preparations, urinary calculus solvents. Indications: Therapeutic indications: Urolithiasis, oxalate-containing calculi, phosphate-containing calculi, uric acid and urate origin calculi, crystalluria, prevention of recurrence of calculi formation after surgery, mixed crystals of glycolic acid. As an adjunct: Urinary tract infection, urinary tract infection during pregnancy, nonspecific urethritis, cystitis, pyelitis, burning sensation during urination, gout and hyperuricemia, urinary incontinence in women. Sialolithiasis. Dosage and Administration: As a therapeutic agent: For urolithiasis and crystalluria: 2 tablets 2-3 times daily for 4-6 weeks or until calculi are expelled. For urinary tract infection: 2 tablets 2-3 times daily until the infectious process subsides. For recurrent urinary tract infection: 2 tablets 2-3 times daily for 6-12 weeks. For acute renal colic: 2 tablets 2-3 times daily until symptoms disappear. For burning sensation during urination: 2 tablets 2-3 times daily for 4-5 days or until symptoms disappear. To prevent recurrence of calculi: 1 tablet 2-3 times daily for 4 to 5 months. Side Effects: Allergic reactions may occur. Contraindications: Hypersensitivity to individual components of the preparation. Interaction with other drugs: Not described. Special Instructions: Since the effect of Cystone develops gradually, its use is not recommended for acute pain in the urinary tract, and therefore its use is discontinued. Appearance and Packaging: Round, biconvex tablets, light brown with lighter and darker inclusions. A plastic bottle of 100 tablets with instructions for medical use is placed in a cardboard box. Storage Conditions: Store in a dry place, inaccessible to children, at a temperature of +10 to +30C